Unither Pharmaceuticals is listed on the portfolio pages of IK Partners (portfolio page) and Keensight Capital (portfolio page). IK Partners and Keensight Capital list it as current. IK Partners has owned Unither Pharmaceuticals since 2023, per IK Partners' portfolio page.
Unither Pharmaceuticals is a Healthcare company. Its owner on record, IK Partners, is a buyout firm founded in 1989, headquartered in London, United Kingdom, with €19 billion under management. IK Partners lists 74 companies in the index, 15 of them in Healthcare. Also backed by Keensight Capital.
IK Partners is a European private equity firm that invests in small- and mid-cap companies across Northern and Western Europe.
Read the IK Partners profileKeensight Capital is a European Growth Buyout investor focusing on fast growing and profitable companies in the Technology and Healthcare sectors.
Read the Keensight Capital profileUnither Pharmaceuticals is listed on the portfolio pages of IK Partners (portfolio page) and Keensight Capital (portfolio page). IK Partners and Keensight Capital list it as current. IK Partners has owned Unither Pharmaceuticals since 2023, per IK Partners' portfolio page.
Unither Pharmaceuticals is in Healthcare. Classified from the owner's portfolio label.
IK Partners is headquartered in London, United Kingdom.
IK Partners lists 14 other Healthcare companies in the index, including alanta health group, BIOBank, BOMA, Defibrion and Eurobio Scientific.
6 of 73 shown
See the full IK Partners portfolio.
6 of 55 shown
See the full Keensight Capital portfolio.
Browse PE-backed companies.
